Bayer Buys License For ISIS Pharma's Ant-clotting Drug ISIS-FXIRx
May 04, 2015 at 15:24 PM EDT
Shares of ISIS Pharmaceuticals are up 5% on the news of Bayer AG licensing its anti-clotting drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.